Cargando…
Reasons for not reaching or using web-based self-management applications, and the use and evaluation of Oncokompas among cancer survivors, in the context of a randomised controlled trial
INTRODUCTION: The web-based self-management application Oncokompas was developed to support cancer survivors to monitor health-related quality of life and symptoms (Measure) and to provide tailored information (Learn) and supportive care options (Act). In a previously reported randomised controlled...
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350584/ https://www.ncbi.nlm.nih.gov/pubmed/34401388 http://dx.doi.org/10.1016/j.invent.2021.100429 |
| _version_ | 1783735796885356544 |
|---|---|
| author | van der Hout, A. van Uden-Kraan, C.F. Holtmaat, K. Jansen, F. Lissenberg-Witte, B.I. Nieuwenhuijzen, G.A.P. Hardillo, J.A. Baatenburg de Jong, R.J. Tiren-Verbeet, N.L. Sommeijer, D.W. de Heer, K. Schaar, C.G. Sedee, R.J.E. Bosscha, K. van den Brekel, M.W.M. Petersen, J.F. Westerman, M. Honings, J. Takes, R.P. Houtenbos, I. van den Broek, W.T. de Bree, R. Jansen, P. Eerenstein, S.E.J. Leemans, C.R. Zijlstra, J.M. Cuijpers, P. van de Poll-Franse, L.V. Verdonck-de Leeuw, I.M. |
| author_facet | van der Hout, A. van Uden-Kraan, C.F. Holtmaat, K. Jansen, F. Lissenberg-Witte, B.I. Nieuwenhuijzen, G.A.P. Hardillo, J.A. Baatenburg de Jong, R.J. Tiren-Verbeet, N.L. Sommeijer, D.W. de Heer, K. Schaar, C.G. Sedee, R.J.E. Bosscha, K. van den Brekel, M.W.M. Petersen, J.F. Westerman, M. Honings, J. Takes, R.P. Houtenbos, I. van den Broek, W.T. de Bree, R. Jansen, P. Eerenstein, S.E.J. Leemans, C.R. Zijlstra, J.M. Cuijpers, P. van de Poll-Franse, L.V. Verdonck-de Leeuw, I.M. |
| author_sort | van der Hout, A. |
| collection | PubMed |
| description | INTRODUCTION: The web-based self-management application Oncokompas was developed to support cancer survivors to monitor health-related quality of life and symptoms (Measure) and to provide tailored information (Learn) and supportive care options (Act). In a previously reported randomised controlled trial (RCT), 68% of 655 recruited survivors were eligible, and of those 45% participated in the RCT. Among participants of the RCT that were randomised to the intervention group, 52% used Oncokompas as intended. The aim of this study was to explore reasons for not participating in the RCT, and reasons for not using Oncokompas among non-users, and the use and evaluation of Oncokompas among users. METHODS: Reasons for not participating were assessed with a study-specific questionnaire among 243 survivors who declined participation. Usage was investigated among 320 participants randomised to the intervention group of the RCT via system data and a study-specific questionnaire that was assessed during the 1 week follow-up (T1) assessment. RESULTS: Main reasons for not participating were not interested in participation in scientific research (40%) and not interested in scientific research and Oncokompas (28%). Main reasons for not being interested in Oncokompas were wanting to leave the period of being ill behind (29%), no symptom burden (23%), or lacking internet skills (18%). Out of the 320 participants in the intervention group 167 (52%) used Oncokompas as intended. Among 72 non-users, main reasons for not using Oncokompas were no symptom burden (32%) or lack of time (26%). Among 248 survivors that activated their account, satisfaction and user-friendliness were rated with a 7 (scale 0–10). Within 3 (IQR 1–4) sessions, users selected 32 (IQR 6–37) topics. Main reasons for not using healthcare options in Act were that the information in Learn was already sufficient (44%) or no supportive care needs (32%). DISCUSSION: Main reasons for not reaching or using Oncokompas were no symptom burden, no supportive care needs, or lack of time. Users selected many cancer-generic and tumour-specific topics to address, indicating added value of the wide range of available topics. |
| format | Online Article Text |
| id | pubmed-8350584 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83505842021-08-15 Reasons for not reaching or using web-based self-management applications, and the use and evaluation of Oncokompas among cancer survivors, in the context of a randomised controlled trial van der Hout, A. van Uden-Kraan, C.F. Holtmaat, K. Jansen, F. Lissenberg-Witte, B.I. Nieuwenhuijzen, G.A.P. Hardillo, J.A. Baatenburg de Jong, R.J. Tiren-Verbeet, N.L. Sommeijer, D.W. de Heer, K. Schaar, C.G. Sedee, R.J.E. Bosscha, K. van den Brekel, M.W.M. Petersen, J.F. Westerman, M. Honings, J. Takes, R.P. Houtenbos, I. van den Broek, W.T. de Bree, R. Jansen, P. Eerenstein, S.E.J. Leemans, C.R. Zijlstra, J.M. Cuijpers, P. van de Poll-Franse, L.V. Verdonck-de Leeuw, I.M. Internet Interv Full length Article INTRODUCTION: The web-based self-management application Oncokompas was developed to support cancer survivors to monitor health-related quality of life and symptoms (Measure) and to provide tailored information (Learn) and supportive care options (Act). In a previously reported randomised controlled trial (RCT), 68% of 655 recruited survivors were eligible, and of those 45% participated in the RCT. Among participants of the RCT that were randomised to the intervention group, 52% used Oncokompas as intended. The aim of this study was to explore reasons for not participating in the RCT, and reasons for not using Oncokompas among non-users, and the use and evaluation of Oncokompas among users. METHODS: Reasons for not participating were assessed with a study-specific questionnaire among 243 survivors who declined participation. Usage was investigated among 320 participants randomised to the intervention group of the RCT via system data and a study-specific questionnaire that was assessed during the 1 week follow-up (T1) assessment. RESULTS: Main reasons for not participating were not interested in participation in scientific research (40%) and not interested in scientific research and Oncokompas (28%). Main reasons for not being interested in Oncokompas were wanting to leave the period of being ill behind (29%), no symptom burden (23%), or lacking internet skills (18%). Out of the 320 participants in the intervention group 167 (52%) used Oncokompas as intended. Among 72 non-users, main reasons for not using Oncokompas were no symptom burden (32%) or lack of time (26%). Among 248 survivors that activated their account, satisfaction and user-friendliness were rated with a 7 (scale 0–10). Within 3 (IQR 1–4) sessions, users selected 32 (IQR 6–37) topics. Main reasons for not using healthcare options in Act were that the information in Learn was already sufficient (44%) or no supportive care needs (32%). DISCUSSION: Main reasons for not reaching or using Oncokompas were no symptom burden, no supportive care needs, or lack of time. Users selected many cancer-generic and tumour-specific topics to address, indicating added value of the wide range of available topics. Elsevier 2021-07-15 /pmc/articles/PMC8350584/ /pubmed/34401388 http://dx.doi.org/10.1016/j.invent.2021.100429 Text en © 2021 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Full length Article van der Hout, A. van Uden-Kraan, C.F. Holtmaat, K. Jansen, F. Lissenberg-Witte, B.I. Nieuwenhuijzen, G.A.P. Hardillo, J.A. Baatenburg de Jong, R.J. Tiren-Verbeet, N.L. Sommeijer, D.W. de Heer, K. Schaar, C.G. Sedee, R.J.E. Bosscha, K. van den Brekel, M.W.M. Petersen, J.F. Westerman, M. Honings, J. Takes, R.P. Houtenbos, I. van den Broek, W.T. de Bree, R. Jansen, P. Eerenstein, S.E.J. Leemans, C.R. Zijlstra, J.M. Cuijpers, P. van de Poll-Franse, L.V. Verdonck-de Leeuw, I.M. Reasons for not reaching or using web-based self-management applications, and the use and evaluation of Oncokompas among cancer survivors, in the context of a randomised controlled trial |
| title | Reasons for not reaching or using web-based self-management applications, and the use and evaluation of Oncokompas among cancer survivors, in the context of a randomised controlled trial |
| title_full | Reasons for not reaching or using web-based self-management applications, and the use and evaluation of Oncokompas among cancer survivors, in the context of a randomised controlled trial |
| title_fullStr | Reasons for not reaching or using web-based self-management applications, and the use and evaluation of Oncokompas among cancer survivors, in the context of a randomised controlled trial |
| title_full_unstemmed | Reasons for not reaching or using web-based self-management applications, and the use and evaluation of Oncokompas among cancer survivors, in the context of a randomised controlled trial |
| title_short | Reasons for not reaching or using web-based self-management applications, and the use and evaluation of Oncokompas among cancer survivors, in the context of a randomised controlled trial |
| title_sort | reasons for not reaching or using web-based self-management applications, and the use and evaluation of oncokompas among cancer survivors, in the context of a randomised controlled trial |
| topic | Full length Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350584/ https://www.ncbi.nlm.nih.gov/pubmed/34401388 http://dx.doi.org/10.1016/j.invent.2021.100429 |
| work_keys_str_mv | AT vanderhouta reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT vanudenkraancf reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT holtmaatk reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT jansenf reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT lissenbergwittebi reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT nieuwenhuijzengap reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT hardilloja reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT baatenburgdejongrj reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT tirenverbeetnl reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT sommeijerdw reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT deheerk reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT schaarcg reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT sedeerje reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT bosschak reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT vandenbrekelmwm reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT petersenjf reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT westermanm reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT honingsj reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT takesrp reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT houtenbosi reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT vandenbroekwt reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT debreer reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT jansenp reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT eerensteinsej reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT leemanscr reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT zijlstrajm reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT cuijpersp reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT vandepollfranselv reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial AT verdonckdeleeuwim reasonsfornotreachingorusingwebbasedselfmanagementapplicationsandtheuseandevaluationofoncokompasamongcancersurvivorsinthecontextofarandomisedcontrolledtrial |